Charles Riv Lab Rg
CRL
USD
STOCK MARKET:
NYX
Closed
 
...
Price in deferred time of 15 minutes
Last quote
07/15/2024 - 16:15:00
Bid
07/15/2024 - 16:00:00
Bid
Volume
Ask
07/15/2024 - 16:00:00
Ask
Volume
216.25
+0.06 ( +0.03% )
216.27
2,000
216.34
1,000
More information
Analysis by TheScreener
12.07.2024
Evaluation Neutral  
Interest None  
Sensibility Middle  
Analysis date: 12.07.2024
Global Evaluation
  Neutral
The stock is classified in the neutral zone since 05.03.2024.
Interest
  None
No interest since 10.05.2024.
Earnings Rev Trend
  -0.10
 
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is negative since 10.05.2024 at a price of 228.12.
Evaluation
  Overvalued
 
Based on its growth potential and our own criteria, at its current price the stock is moderately overvalued.
MT Tech Trend
  Neutral
 
The stock is currently trading close to its forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this (since 12.04.2024), the stock traded below its moving average. The confirmed Technical Reverse (Tech Reverse + 1.75%) point is .
4wk Rel Perf
  -2.49%
 
The four week relative underperformance versus SP500 is 2.49%.
Sensibility
  Middle
The stock has been on the moderate-sensitivity level since 05.03.2024.
Bear Market Factor
  Middle
On average, the stock is likely to decline with the index.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 2.90%.
Mkt Cap in $bn
  10.86
With a market capitalization >$8bn, CHARLES RIVER LAB is considered a large-cap stock.
G/PE Ratio
  0.82
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential: premium.
LT P/E
  15.75
The estimated PE is for the year 2026.
LT Growth
  12.91%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
  16
Over the last seven weeks, an average of 16 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  150
For 1% of index variation, the stock varies on average by 1.50%.
Correlation
  0.55
54.71% of stock movements are explained by index variations.
Value at Risk
  51.89
The value at risk is estimated at USD 51.89. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  31.03.2004